What is 3D Bio - Tissues?
3D Bio - Tissues is an ambitious startup focused on commercializing functional tissue-engineered products. The company distinguishes itself with a proprietary technology that replicates the nanoscale structural features of living tissue, enabling the creation of truly functional, scaffold-free lab-grown meat. As a wholly-owned subsidiary of the LSE-listed BSF enterprise, 3D Bio - Tissues benefits from substantial financial resources and a unique market position within the food technology sector.
How much funding has 3D Bio - Tissues raised?
3D Bio - Tissues has raised a total of $1.9M across 1 funding round:
Grant
$1.9M
Grant (2023): $1.9M with participation from EIT Food
Key Investors in 3D Bio - Tissues
EIT Food
EIT Food is Europe's leading food innovation initiative, aiming to create a sustainable and future-proof food sector through collaboration with industry, startups, and research institutions. It supports high-potential agrifood startups and scaleups.
What's next for 3D Bio - Tissues?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for 3D Bio - Tissues. This capital infusion is expected to accelerate the company's research and development efforts, scale production capabilities, and further solidify its leadership in the scaffold-free lab-grown meat market. The company's focus on creating 100% lab-grown meat, combined with its unique technological approach, positions it for significant expansion and market penetration.
See full 3D Bio - Tissues company page
